Genomind® Professional PGx^TM is a genetic test created to assist clinicians in optimizing treatment decisions for patients with a mental illness. The test examines patient-specific genetic markers that can identify treatments that are more likely to work as intended, not have an effect, or cause a negative effect. It is a quickly administered cheek swab test that evaluates key genes, chosen based on hundreds of studies that show variations in these genes can help inform treatment choices for mental disorders.

Genomind Professional PGx is used to guide treatment for a range of psychiatric conditions, including:

• major depression
• anxiety disorder
• obsessive-compulsive disorder (OCD)
• attention deficit hyperactivity disorder (ADHD)
• bipolar disorder

• post traumatic stress disorder (PTSD)
• autism
• schizophrenia
• personality disorder
• chronic pain
• substance abuse

Watch a short overview

Peer reviewed published studies have show that Genomind Professional PGx may improve a patient’s mental health and lessen overall medical costs. Each test provides clinicians with a simple patient report and includes a psychopharmacogenomic consultation.